2000Unpublished venueRequires access

Effects of pentoxifylline on adhesion molecules expression in lung ischemia-reperfusion injury in rats

Niu Hui

Open publisher page 0 citations

Abstract

Objective To study the effect of pentoxifylline on the expression of the CD18 and ICAM 1 after lung ischemia/reperfusion injury in rats. Methods The rat model of lung ischemia was estaleished with occlusion of left pulmonary hilus for 45 min. Seventy two rats were divided into 3 groups: ① Sham operation group (GroupⅠ, n =24); ②Ischemia reperfusion injury group (GroupⅡ, n =24); ③Pentoxifylline treatment group (GroupⅢ, n =24). Pentoxifylline was injected intravenously 5 min before and 45 min after normothermic ischemia. The changes of water content of lung, MPO and BALF albumin were studied 1 h, 2 h, 4 h during reperfusion after 45 min pulmonary ischemia. Flow cytometric analysis and immunohistochemistry were used to assess the expression of the CD18 on the polymorphonuclear neutrophil(PMN) and ICAM 1 on lung tissue. Results In groupⅡ, water content of lung, MPO and BALF albumin were increased evidently ( P 0.05), the expression of CD18 and ICAM 1 were up regulated. In groupⅢ, the changes were ameliorated as compared with groupⅡ. Conclusion Pentoxifylline can reduce the aggregation and activation of PMNs in the lungs through its effect to inhibit the expression of CD11/CD18 and ICAM 1 after pulmonary ischemia reperfusion. Consequently pulmonary ischemia repefusion injury is prevented.

About this research paper

What this paper is about

Objective To study the effect of pentoxifylline on the expression of the CD18 and ICAM 1 after lung ischemia/reperfusion injury in rats. Methods The rat model of lung ischemia was estaleished with occlusion of left pulmonary hilus for 45 min. Seventy two rats were divided into 3 groups: ① Sham operation group (GroupⅠ, n =24); ②Ischemia reperfusion injury group (GroupⅡ, n =24); ③Pentoxifylline treatment group (GroupⅢ, n =24). Pentoxifylline was injected intravenously 5 min before and 45 min after normothermic ischemia. The changes of water content of lung, MPO and BALF albumin were studied 1 h, 2 h, 4 h during reperfusion after 45 min pulmonary ischemia. Flow cytometric analysis and immunohistochemistry were used to assess the expression of the CD18 on the polymorphonuclear neutrophil(PMN) and ICAM 1 on lung tissue. Results In groupⅡ, water content of lung, MPO and BALF albumin were increased evidently ( P 0.05), the expression of CD18 and ICAM 1 were up regulated. In groupⅢ, the changes were ameliorated as compared with groupⅡ. Conclusion Pentoxifylline can reduce the aggregation and activation of PMNs in the lungs through its effect to inhibit the expression of CD11/CD18 and ICAM 1 after pulmonary ischemia reperfusion. Consequently pulmonary ischemia repefusion injury is prevented.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the effect of pentoxifylline on the expression of the CD18 and ICAM 1 after lung ischemia/reperfusion injury in rats. Methods The rat model of lung ischemia was estaleished with occlusion of left pulmonary hilus for 45 min. Seventy two rats were divided into 3 groups: ① Sham operation group (GroupⅠ, n =24); ②Ischemia reperfusion injury group (GroupⅡ, n =24); ③Pentoxifylline treatment group (GroupⅢ, n =24). Pentoxifylline was injected intravenously 5 min before and 45 min after normothermic ischemia. The changes of water content of lung, MPO and BALF albumin were studied 1 h, 2 h, 4 h during reperfusion after 45 min pulmonary ischemia. Flow cytometric analysis and immunohistochemistry were used to assess the expression of the CD18 on the polymorphonuclear neutrophil(PMN) and ICAM 1 on lung tissue. Results In groupⅡ, water content of lung, MPO and BALF albumin were increased evidently ( P 0.05), the expression of CD18 and ICAM 1 were up regulated. In groupⅢ, the changes were ameliorated as compared with groupⅡ. Conclusion Pentoxifylline can reduce the aggregation and activation of PMNs in the lungs through its effect to inhibit the expression of CD11/CD18 and ICAM 1 after pulmonary ischemia reperfusion. Consequently pulmonary ischemia repefusion injury is prevented.

Key concepts: Pentoxifylline, Ischemia, Medicine, Lung, Reperfusion injury, CD18, Albumin, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of pentoxifylline on adhesion molecules expression in lung ischemia-reperfusion injury in rats — Research Paper | ScholarLens